Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy

INTRODUCTION: Perioperative treatment in NSCLC has gained marked attention with the introduction of immune checkpoint inhibitors. Such a paradigm shift has given us additional opportunities to evaluate potential biomarkers in patients with these curable disease stages. METHODS: This study (WJOG12319...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanizaki, Junko, Kuroda, Hiroaki, Yokoyama, Toshihide, Takahama, Makoto, Shoda, Hiroyasu, Nakamura, Atsushi, Kitamura, Yoshitaka, Mamesaya, Nobuaki, Kadota, Yoshihisa, Sawa, Kenji, Okishio, Kyoichi, Okada, Morihito, Suminaka, Chihiro, Noda, Kenta, Sakai, Kazuko, Chiba, Yasutaka, Nishio, Kazuto, Chamoto, Kenji, Honjo, Tasuku, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko, Hayashi, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679776/
https://www.ncbi.nlm.nih.gov/pubmed/38029041
http://dx.doi.org/10.1016/j.jtocrr.2023.100590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679776/
https://www.ncbi.nlm.nih.gov/pubmed/38029041
http://dx.doi.org/10.1016/j.jtocrr.2023.100590

Ejemplares similares